Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues

Haematologica

Volumn 102, Issue 8, 2017, Pages 1324-1332

  de Moerloose, Philippe ^a   Fickentscher, Céline ^a   Boehlen, Françoise ^a   Tiercy, Jean Marie ^a   Kruithof, Egbert K O ^a   Brandt, Karim J ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; COMPLEMENTARY DNA; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; HLA ANTIGEN CLASS 2; HYBRID PROTEIN; PEPTIDE FRAGMENT; PHOSPHOLIPID ANTIBODY; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR; AUTOANTIBODY; EPITOPE;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; BLOOD BUFFY COAT; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; POINT MUTATION; PROTEIN EXPRESSION; PROTEIN MOTIF; RISK FACTOR; CHEMISTRY; IMMUNOLOGY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; EPITOPES; HUMANS;

EID: 85026726700     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2017.170381     Document Type: Article

References (36)

1. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368(11):1033-1044.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
3. Agar C, van Os GM, Morgelin M, et al. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood. 2010;116(8):1336-1343.
4. de Laat B, van Berkel M, Urbanus RT, et al. Immune responses against domain I of beta(2)-glycoprotein I are driven by conformational changes: domain I of beta(2)-glycoprotein I harbors a cryptic immunogenic epitope. Arthritis Rheum. 2011; 63(12):3960-3968.
5. de Laat B, Derksen RH, van Lummel M, Pennings MT, de Groot PG. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood. 2006; 107(5):1916-1924.
6. Iverson GM, Reddel S, Victoria EJ, et al. Use of single point mutations in domain I of beta(2)-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol. 2002; 169(12):7097-7103.
7. Ioannou Y, Pericleous C, Giles I, et al. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum. 2007;56(1):280-290.
8. Khattri S, Zandman-Goddard G, Peeva E. B-cell directed therapies in antiphospholipid antibody syndrome--new directions based on murine and human data. Autoimmun Rev. 2012;11(10):717-722.
9. Cousins L, Pericleous C, Khamashta M, et al. Antibodies to domain I of beta-2-glycopro-tein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome. Ann Rheum Dis. 2015;74(1):317-319.
10. Hattori N, Kuwana M, Kaburaki J, et al. T cells that are autoreactive to beta(2)-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum. 2000;43(1):65-75.
11. Arai T, Yoshida K, Kaburaki J, et al. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood. 2001;98(6):1889-1896.
12. Ito H, Matsushita S, Tokano Y, et al. Analysis of T cell responses to the β2-glycoprotein I-derived peptide library in patients with anti-β2-glycoprotein I antibody-associ-ated autoimmunity. Hum Immunol. 2000;61(4):366-377.
13. Brandt KJ, Kruithof EKO, de Moerloose P. Receptors involved in cell activation by antiphospholipid antibodies. Thromb Res. 2013;132(4):408-413.
14. de Laat B, de Groot PG. Autoantibodies directed against domain I of beta2-glycoprotein I. Curr Rheumatol Rep. 2011;13(1):70-76.
15. Vlachoyiannopoulos PG, Mavragani CP, Bourazopoulou E, Balitsari AV, Routsias JG. Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythemato-sus. Thromb Haemost. 2004;92(6):1303-1311.
16. Tanimura K, Jin H, Suenaga T, et al. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood. 2015;125(18):2835-2844.
17. Domenico Sebastiani G, Minisola G, Galeazzi M. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Autoimmun Rev. 2003;2(6):387-394.
18. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem. 2002;277(48):46478-46486.
19. Smith LR, Bost KL, Blalock JE. Generation of idiotypic and anti-idiotypic antibodies by immunization with peptides encoded by complementary RNA: a possible molecular basis for the network theory. J Immunol. 1987;138(1):7-9.
20. Pendergraft WF, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004; 10(1):72-79.
21. Žager U, Lunder M, Hodnik V, et al. Significance of K(L/V)WX(I/L/V)P Epitope of the B2Gpi in Its (Patho)Physiologic Function. EJIFCC. 2011;22(4):118-124.
22. Blank M, Krouse I, Fridkin M, et al. Bacterial induction of autoantibodies to b2-glycopro-tein-1 accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002;109:797-804.
23. Toyoshima M, Maegaki Y, Yotsumata K, Takei S, Kawano Y. Antiphospholipid syndrome associated with human herpesvirus-6 infection. Pediatr Neurol. 2007;37(6):449-451.
24. Grunewald T, Burmester GR, Schuler-Maue W, Hiepe F, Buttgereit F. Anti-phospholipid antibodies and CD5+ B cells in HIV infection. Clin Exp Immunol. 1999;115(3):464-471.
25. Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus. 2016;25(14):1520-1531.
26. Durkin ML, Marchese D, Robinson MD, Ramgopal M. Catastrophic antiphospholipid syndrome (CAPS) induced by influenza A virus subtype H1N1. BMJ Case Rep. 2013;2013: bcr2013200474.
27. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen includes a lipid-binding inhibitor of coagulation: B2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 1990;87:4120-4124.
28. Satta N, Dunoyer-Geindre S, Reber G, et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood. 2007; 109(4):1507-1514.
29. Lutters BC, Derksen RH, Tekelenburg WL, et al. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem. 2003;278(36):33831-33838.
30. Döring Y, Hurst J, Lorenz M, et al. Human antiphospholipid antibodies induce TNFα in monocytes via Toll-like receptor 8. Immunobiology. 2010;215(3):230-241.
31. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood. 2009;114:3074-3083.
32. Brandt KJ, Fickentscher C, Boehlen F, Kruithof EK, de Moerloose P. NF-kappaB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost. 2014;12(5): 779-791.
33. Pierangeli SS, Vega-Ostertag ME, Raschi E, et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis. 2007;66(10):1327-1333.
34. Hurst J, Prinz N, Lorenz M, et al. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1β and caspase-1 in monocytes and dendritic cells. Immunobiology. 2009;214(8):683-691.
35. Aguilar-Valenzuela R, Nickerson K, Romay-Penabad Z, et al. Involvement of TLR7 and TLR9 in the Production of Antiphospholipid Antibodies. Arthritis Rheum. 2011;63(10): S281-S282.
36. Shi T, Giannakopoulos B, Yan X, et al. Anti-β2-glycoprotein I antibodies in complex with β2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum. 2006;54(8):2558-2567.